SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

The sharp rally has no confirmed company-news catalyst; traders are focused on anticipation of the REGAL Phase 3 final analysis, which is triggered at 80 survival events after the last disclosed count of 78. Some interpret the CEOs anniversary message and SELLASs planned ASH presence as signs of a potential buyout, while others call that speculation and see the move as a rebound or possible short covering.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly earnings report is the dominant focus, with traders watching guidance, subscriber engagement and advertising growth amid concerns about competition and a prolonged share-price decline. Many expect further weakness, while bulls argue pessimism is already priced in and see room for a rebound if results or the outlook are stronger than feared.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is drawing attention as traders position around the full Phase 3 melanoma results for its personalized cancer vaccine, intismeran, with Merck; the prior positive topline result has fueled a sharp rally. Bulls see validation of a broader oncology platform, while skeptics warn that expectations and valuation are stretched and debate a possible sell-the-news reaction.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

SRPTs sharp rebound is being attributed by traders to possible short covering and anticipation of upcoming DM1 and FSHD siRNA data, with Arrowheads RNAi results cited as supportive context. No new Sarepta catalyst is confirmed in the discussion, and some traders view the move as technical or part of broader biotech strength.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IRENs steep selloff is being discussed amid broader neocloud concerns about financing, AI infrastructure spending returns, and whether providers can remain independent; traders also point to dilution and possible project delays. The community is split between bearish views that the weakness may persist and bullish arguments that IRENs cash-funded data centers and customer prepayments distinguish it from more debt-heavy peers.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs quarterly earnings beat and new share-repurchase authorization are being overshadowed by a narrowed full-year profit outlook whose midpoint was unchanged, prompting a sharp selloff. Traders are split between viewing the buyback and stronger cash-flow outlook as support and seeing cautious guidance, lower U.S. sales, and cost pressures as reasons for the decline.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solanas volatile pullback and bounce amid broader crypto weakness are driving discussion, with traders watching support and Bitcoins direction. Dip-buyers are accumulating and staking, while bearish traders warn the recovery may fail and expect further downside.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA is drawing attention as it approaches and tests its 200-day moving average ahead of earnings, with traders watching for stronger volume and sustained momentum. Optimism about ASCENIV growth and share repurchases is tempered by calls for earnings to validate the outlook and lingering concerns over BIVIGAM weakness and management credibility.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp is driving the sharp rally, with traders viewing the cash transaction as a potential balance-sheet and strategic reset. Bulls welcome the deal and momentum, while skeptics argue the sale removes a revenue-generating business and leaves concerns about declining operations and debt; the transaction remains subject to approval.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is drawing attention after a sharp post-earnings selloff despite beating expectations, as investors focused on slower U.S. da Vinci procedure growth and a cautious outlook. Traders are split between viewing the decline as an overreaction given the companys robotic-surgery position and recurring revenue, and seeing valuation, competition, and growth uncertainty as reasons for a reset.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

National CineMedia, Inc. Completes Acquisition of Captivate

National CineMedia, Inc. (NASDAQ: NCMI) (NCM), the largest cinema advertising platform in the U.S., announced that on September 18, 2026 it completed its previously announced acquisition of Captivate Holdings, LLC (Captivate), the leading operator of office and residential digital video advertising...

National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures higher, Nasdaq 100 up 150 pts. National CineMedia shares down 16.4% on weak Q2 results and Captivate Holdings acquisition. Other stocks also falling in pre-market trading.read more...

National CineMedia (NCMI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for National CineMedia (NCMI) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Generation Partners announces sale of Captivate Network to National CineMedia (NASDAQ: NCMI)

Generation Partners announces sale of Captivate Network to National CineMedia (NASDAQ: NCMI) Generation Partners announces sale of Captivate Network to National CineMedia (NASDAQ: NCMI) PR Newswire GREENWICH, Conn. and AUSTIN, Texas and LOS ANGELES, Aug. 11, 2026 GREENWICH, Conn. and AUSTIN, Texas...

National CineMedia (NCMI) Reports Q2 Loss, Lags Revenue Estimates

National CineMedia (NCMI) delivered earnings and revenue surprises of -11.11% and -3.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

National CineMedia, Inc. Reports Results for Fiscal Second Quarter 2026

National CineMedia, Inc. (NASDAQ: NCMI) (the Company or NCM), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., today announced its consolidated results for the fiscal second quarter ended July 2, 2026. NCM delivered...

National CineMedia, Inc. to Acquire Captivate for $275 Million, Creating the Leading Premium Video and Digital Out-of-Home Advertising Platform

National CineMedia, Inc. (NASDAQ: NCMI) (NCM), the largest cinema advertising platform in the U.S., today announced that it has entered into a definitive agreement to acquire Captivate Holdings, LLC (Captivate), the leading operator of digital video elevator and lobby advertising in North America...

Fluent (FLNT) Reports Q2 Loss, Beats Revenue Estimates

Fluent (FLNT) delivered earnings and revenue surprises of +13.33% and +5.02%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Curious about National CineMedia (NCMI) Q2 Performance? Explore Wall Street Estimates for Key Metrics

Besides Wall Street's top-and-bottom-line estimates for National CineMedia (NCMI), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.

National CineMedia, Inc. to Release Second Quarter 2026 Results on August 11, 2026

National CineMedia, Inc. (NASDAQ: NCMI), the managing member of National CineMedia, LLC (NCM LLC), the operator of the largest cinema advertising platform in the U.S., plans to issue its second quarter 2026 earnings results after the market closes on Tuesday, August 11, 2026. A conference call and...

National CineMedia, Inc. is a holding company which engages in the provision of various advertising, business meetings, event services, and third-party theatre circuits under network affiliate agreements. It mainly operates as a cinema advertising platform. National CineMedia was founded on October 5, 2006 and is headquartered in Centennial, CO.

National Cinemedia Inc

 National CineMedia Stock Poised To Open At 8-Month Low After Q4 Revenue Dips, Guidance Underwhelms: Retail Stays On Sidelines

Equity

Bearish Sentiment

National CineMedia, Inc. (NCMI) shares plunged in Thursday’s after-hours session after the cinema advertising platform announced a fourth-quarter revenue decline and a subpar guidance for the current quarter.The Centennial, Colorado-based company reported earnings per share (EPS) of $0.26 for the fourth quarter of the fiscal year 2024, up from the $0.24 per share reported for the year-ago period.Revenue fell 5.1% year over year (YoY) to $86.3 million, with the company attributing the decline to an unfavorable slate and the prior year's outperformance of “Taylor Swift: The Eras Tour.”&nbsp;Howevet, the topline exceeded the Finchat-compiled consensus of $84.77 million.&nbsp;Adjusted operating income before depreciation and amortization (OIBDA), a non-GAAP measure, fell YoY to $35 million from $39.8 million.Tom Lesinski, CEO of National CineMedia said the company’s advertising network continued to deliver value with its NCMx data platform, driving measurable return on investment (ROI).&nbsp;&nbsp;National CineMedia expects first-quarter revenue of $34 million to $36 million and an adjusted OIBDA of negative $9.5 million to negative $7.5 million.&nbsp; The consensus calls for revenue of $39.53 million for the quarter.This company said the guidance reflected lower expected impressions in the first quarter and temporarily delayed advertising spend due to reductions in government spending impacting advertising as well as the ongoing tariff uncertainty impacting certain categories.&nbsp;However, it remained optimistic about the first half based on robust second-quarter sales pacing.On Stocktwits, the retail sentiment toward National CineMedia stock remained ‘neutral’ (50/100), with the message volume coming to a standstill from the ‘extremely low’ activity seen a week ago.<figure class="image"><img style="aspect-ratio:636/128;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ncmi_sentiment_a0091a7578.png" alt="ncmi_sentiment.png" width="636" height="128"><figcaption>NCMI sentiment and message volume March 7, as of 2:51 am ET | Source:&nbsp;Stocktwits</figcaption></figure>National CineMedia stock slumped 8.66% to $5.80 in the after-hours session on Thursday, the lowest level in eight months. The stock is down nearly 4.4% so far this year.For updates and corrections email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/most-retailers-brace-for-further-market-decline/chepCguRbG0">We Asked Retail Traders How They’re Playing Trump’s Tariff Moves: Most See Opportunity Or Want To Wait It Out</a>

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

The quarterly revenue decline was due to an unfavorable slate and the prior year's outperformance of “Taylor Swift: The Eras Tour.”

National CineMedia Stock Poised To Open At 8-Month Low After Q4 Revenue Dips, Guidance Underwhelms: Retail Stays On Sidelines

The quarterly revenue decline was due to an unfavorable slate and the prior year's outperformance of “Taylor Swift: The Eras Tour.”


Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Current Price	$2.03
Prev Close	$2.08
Open	$2.09
Dividend Yield	3.08%
50-Day Moving Average	$2.43
Beta	0.84
Avg. Volume	1.17M
PE Ratio	-25.12

52-Week High	$4.56
52-Week Low	$1.99
Market Capitalization	$195.67M
EPS (Annual)	-$0.1126
Price to Book	0.58
Revenue Per Employee	$980,645.16

Feed

News

Sentiment

Earnings

Fundamentals

Info

NCMI Fundamentals